Reportlinker Adds Impact of Counterfeits on Parallel Trade & Pharmaceutical Distribution: Issues, initiatives and insights for supply chain...(er 5 Global initiatives to combat counte...),Health

Summary 122

International anti-counterfeiting initiatives 123

Government efforts 123

European Commission 123

United States Department of Health & Human Services 126

World Health Organization 127

INTERPOL 129

Non-government efforts 129

UNICEF 129

Medecins Sans Frontieres 130

UNITAID 130

Anti-counterfeiting initiatives in Asia 131

India 131

China 132

Taiwan 134

Pharmaceutical trade and industry organizations 135

Pharmaceutical Security Institute (PSI) 136

International Federation of Pharmaceutical Manufacturers Associations

(IFPMA) 136

European Federation of Pharmaceutical Manufacturers Associations (EFPIA) 137

The European Alliance for Access to Safe Medicines (EAASM) 139

New initiative: Rx-360 139

Stockholm Network 140

Considerations for parallel trade and counterfeiting 140

Key points and recommendations 140

Chapter 6 Appendix 143

Primary research methodology 143

References 143

Websites 144

Glossary 145

Index 147

List of Figures

Figure 1.1: Generalized parallel trade process for pharmaceuticals in Europe 19

Figure 1.2: Major factors contributing to parallel trade in the EU 28

Figure 1.3: Advantages & disadvantages of parallel trade 32

Figure 1.4: Estimated market penetration of parallel imports by value in key European destinations (%), 2001 & 2009 37

Figure 2.5: Key opposing issues on parallel importation from Canada 53

Figure 2.6: Prescription drugs typically imported into the US 56

Figure 2.7: Typical savings offered by a Canadian online pharmacy, 2009 58

Figu
'/>"/>